HLA-B27
Showing 1 - 25 of >10,000
Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)
Completed
- Uveitis
- Norflo Oro
- Placebo for Norflo Oro
-
Miami, FloridaBascom Palmer Eye Institute
Mar 25, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Seattle (Allogeneic Hematopoietic
Recruiting
- Acute Lymphoblastic Leukemia
- +16 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 1, 2022
Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS) Trial in Marseille (blood samples)
Completed
- Axial Spondyloarthritis (axSpA)
- Ankylosing Spondylitis (AS)
- blood samples
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Aug 31, 2022
Diffuse Midline Glioma, H3 K27M-Mutant Trial in San Francisco (Cyclophosphamide, Fludarabine, Autologous Anti-H3.3K27M
Not yet recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Cyclophosphamide
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial in Boston (Pembrolizumab, PVX-410)
Active, not recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Pembrolizumab
- PVX-410
-
Boston, Massachusetts
- +2 more
Dec 21, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Axial Spondyloarthritis, Psoriatic Arthritis Trial in Istanbul (serum raftlin-1 protein levels)
Recruiting
- Axial Spondyloarthritis
- Psoriatic Arthritis
- serum raftlin-1 protein levels
-
Istanbul, TurkeyBezmialem University
Mar 22, 2023
B-Cell Lymphoid Malignancies, Hematologic Malignancy, Non-Hodgkin Lymphoma Trial in Miami (Hematopoietic Stem Cells from
Recruiting
- B-Cell Lymphoid Malignancies
- +2 more
- Hematopoietic Stem Cells from HLA-compatible Related
- Hematopoietic Stem Cells from HLA Unrelated
-
Miami, FloridaMiami Cancer Institute at Baptist Health of South Florida
May 5, 2022
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Hematologic Diseases, Hematologic Malignancy, Acute Lymphoblastic Leukemia Trial in Miami (device, procedure, drug)
Withdrawn
- Hematologic Diseases
- +5 more
- CliniMACS
- +7 more
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Sep 26, 2022
Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial (PACE CART19)
Withdrawn
- Acute Lymphoblastic Leukemia
- +2 more
- PACE CART19
- (no location specified)
Mar 9, 2022
IBP Criteria & Activity Scores in Patients With AxSpA
Completed
- Axial Spondyloarthritis
- Inflammatory Back Pain
-
Zagazig, Sharqia, EgyptZagazig university
Jan 24, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +10 more
- Busulfan
- +10 more
-
Jacksonville, Florida
- +5 more
Aug 14, 2023
Axial Spondyloarthritis Trial in Bothell (Dietary recommendations)
Terminated
- Axial Spondyloarthritis
- Dietary recommendations
-
Bothell, WashingtonViome Research Institute online: https://www.viome.com/VRI/studi
Jul 5, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, California
- +1 more
Sep 22, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
Sickle Cell Disease Trial in Canada, United States (Alemtuzumab intravenously, low dose total body irradiation, Sirolimus)
Recruiting
- Sickle Cell Disease
- Alemtuzumab intravenously, low dose total body irradiation, Sirolimus
-
Washington, District of Columbia
- +5 more
Mar 2, 2022
B-cell Non Hodgkin Lymphoma Trial in Hangzhou (anti-CD19 CAR-NK)
Recruiting
- B-cell Non Hodgkin Lymphoma
- anti-CD19 CAR-NK
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
May 13, 2021
Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,
Active, not recruiting
- Acute Lymphoid Leukemia (ALL)
- +5 more
- Hyperfractionated total body irradiation
- +9 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 21, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia
Recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Cyclosporine
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 29, 2022
Pregnant Trial in Wilmington (HEPLISAV-B)
Recruiting
- Pregnant
- HEPLISAV-B
-
Wilmington, North CarolinaPPD Registry Office, Recruiting Nationwide
Mar 31, 2022
Hematologic Diseases Trial in Palo Alto (Allogeneic Stem Cell Transplant, CliniMACS TCR a/ß Reagent Kit and CliniMACS CD19)
Recruiting
- Hematologic Diseases
- Allogeneic Stem Cell Transplant
- CliniMACS TCR α/β Reagent Kit and CliniMACS CD19
-
Palo Alto, CaliforniaLucile Packard Children's Hospital
Feb 2, 2022